These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 22341692)

  • 1. Effect of autologous bone marrow mononuclear cells transplantation in diabetic patients with ST-segment elevation myocardial infarction.
    Sun D; Narsinh K; Wang H; Li C; Li W; Zhang Z; Li J; Cao F
    Int J Cardiol; 2013 Jul; 167(2):537-47. PubMed ID: 22341692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Administration of intracoronary bone marrow mononuclear cells on chronic myocardial infarction improves diastolic function.
    Yao K; Huang R; Qian J; Cui J; Ge L; Li Y; Zhang F; Shi H; Huang D; Zhang S; Sun A; Zou Y; Ge J
    Heart; 2008 Sep; 94(9):1147-53. PubMed ID: 18381377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term myocardial functional improvement after autologous bone marrow mononuclear cells transplantation in patients with ST-segment elevation myocardial infarction: 4 years follow-up.
    Cao F; Sun D; Li C; Narsinh K; Zhao L; Li X; Feng X; Zhang J; Duan Y; Wang J; Liu D; Wang H
    Eur Heart J; 2009 Aug; 30(16):1986-94. PubMed ID: 19508995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of intracoronary autologous bone marrow mononuclear cells transplantation in patients with anterior myocardial infarction].
    Wang WM; Sun NL; Liu J; Zhang P; Liu KY; Wang Q; Yang SN; Wang SQ; Zang Y; Guo JH
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Feb; 34(2):103-6. PubMed ID: 16626572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the measurement of left ventricular ejection fraction the proper end point for cell therapy trials? An analysis of the effect of bone marrow mononuclear stem cell administration on left ventricular ejection fraction after ST-segment elevation myocardial infarction when evaluated by cardiac magnetic resonance imaging.
    Traverse JH; Henry TD; Moye' LA
    Am Heart J; 2011 Oct; 162(4):671-7. PubMed ID: 21982659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does mobilisation of CD34+ stem cells along with VEGF, angiogenin, IL-6, IL-8, and hsCRP levels allow predicting the direction of left ventricular ejection fraction and wall motion score index changes in patients with myocardial infarction?
    Grąbczewska Z; Dębski R; Góralczyk K; Świątkiewicz I; Kubica J
    Kardiol Pol; 2013; 71(5):464-71. PubMed ID: 23788086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction.
    Lunde K; Solheim S; Aakhus S; Arnesen H; Abdelnoor M; Egeland T; Endresen K; Ilebekk A; Mangschau A; Fjeld JG; Smith HJ; Taraldsrud E; Grøgaard HK; Bjørnerheim R; Brekke M; Müller C; Hopp E; Ragnarsson A; Brinchmann JE; Forfang K
    N Engl J Med; 2006 Sep; 355(12):1199-209. PubMed ID: 16990383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular systolic and diastolic function improve after acute myocardial infarction treated with acute percutaneous coronary intervention, but are not influenced by intracoronary injection of autologous mononuclear bone marrow cells: a 3 year serial echocardiographic sub-study of the randomized-controlled ASTAMI study.
    Beitnes JO; Gjesdal O; Lunde K; Solheim S; Edvardsen T; Arnesen H; Forfang K; Aakhus S
    Eur J Echocardiogr; 2011 Feb; 12(2):98-106. PubMed ID: 20851818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long term follow-up on emergent intracoronary autologous bone marrow mononuclear cell transplantation for acute inferior-wall myocardial infarction].
    Huang RC; Yao K; Zou YZ; Ge L; Qian JY; Yang J; Yang S; Niu YH; Li YL; Zhang YQ; Zhang F; Xu SK; Zhang SH; Sun AJ; Ge JB
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(16):1107-10. PubMed ID: 16796836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and rationale for the Myocardial Stem Cell Administration After Acute Myocardial Infarction (MYSTAR) Study: a multicenter, prospective, randomized, single-blind trial comparing early and late intracoronary or combined (percutaneous intramyocardial and intracoronary) administration of nonselected autologous bone marrow cells to patients after acute myocardial infarction.
    Nyolczas N; Gyöngyösi M; Beran G; Dettke M; Graf S; Sochor H; Christ G; Edes I; Balogh L; Krause KT; Jaquet K; Kuck KH; Benedek I; Hintea T; Kiss R; Préda I; Kotevski V; Pejkov H; Dudek D; Heba G; Sylven C; Charwat S; Jacob R; Maurer G; Lang I; Glogar D
    Am Heart J; 2007 Feb; 153(2):212.e1-7. PubMed ID: 17239678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial.
    van Ramshorst J; Bax JJ; Beeres SL; Dibbets-Schneider P; Roes SD; Stokkel MP; de Roos A; Fibbe WE; Zwaginga JJ; Boersma E; Schalij MJ; Atsma DE
    JAMA; 2009 May; 301(19):1997-2004. PubMed ID: 19454638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of intracoronary injections of bone-marrow-derived mononuclear cells on large myocardial infarction outcome: quantum of initial necrosis is the key.
    Obradović S; Balint B; Romanovic R; Trifunović Z; Rusović S; Baskot B; Dopudja M; Trifunović G; Rafajlovski S; Jung R; Gligić B
    Vojnosanit Pregl; 2009 Dec; 66(12):998-1004. PubMed ID: 20095521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infarct size determines myocardial uptake of CD34+ cells in the peri-infarct zone: results from a study of (99m)Tc-extametazime-labeled cell visualization integrated with cardiac magnetic resonance infarct imaging.
    Musialek P; Tekieli L; Kostkiewicz M; Miszalski-Jamka T; Klimeczek P; Mazur W; Szot W; Majka M; Banys RP; Jarocha D; Walter Z; Krupinski M; Pieniazek P; Olszowska M; Zmudka K; Pasowicz M; Kereiakes DJ; Tracz W; Podolec P; Wojakowski W
    Circ Cardiovasc Imaging; 2013 Mar; 6(2):320-8. PubMed ID: 23271789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated Intramyocardial Bone Marrow Cell Injection in Previously Responding Patients With Refractory Angina Again Improves Myocardial Perfusion, Anginal Complaints, and Quality of Life.
    Mann I; Rodrigo SF; van Ramshorst J; Beeres SL; Dibbets-Schneider P; de Roos A; Wolterbeek R; Zwaginga JJ; Fibbe WE; Bax JJ; Schalij MJ; Atsma DE
    Circ Cardiovasc Interv; 2015 Aug; 8(8):. PubMed ID: 26259770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A critical challenge: dosage-related efficacy and acute complication intracoronary injection of autologous bone marrow mesenchymal stem cells in acute myocardial infarction.
    Gao LR; Pei XT; Ding QA; Chen Y; Zhang NK; Chen HY; Wang ZG; Wang YF; Zhu ZM; Li TC; Liu HL; Tong ZC; Yang Y; Nan X; Guo F; Shen JL; Shen YH; Zhang JJ; Fei YX; Xu HT; Wang LH; Tian HT; Liu DQ; Yang Y
    Int J Cardiol; 2013 Oct; 168(4):3191-9. PubMed ID: 23651816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes after primary coronary intervention with drug-eluting stent implantation in diabetic patients with acute ST elevation myocardial infarction.
    Zhang Q; Shen J; Zhang RY; Qiu JP; Lu JD; Zhang Y; Chen YH; Zhang JF; Zhang JS; Hu J; Yang ZK; Zheng AF; Zhang X; Shen WF
    Chin Med J (Engl); 2007 Nov; 120(21):1862-7. PubMed ID: 18067756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracoronary injection of bone marrow-derived mononuclear cells early or late after acute myocardial infarction: effects on global left ventricular function.
    Sürder D; Manka R; Lo Cicero V; Moccetti T; Rufibach K; Soncin S; Turchetto L; Radrizzani M; Astori G; Schwitter J; Erne P; Zuber M; Auf der Maur C; Jamshidi P; Gaemperli O; Windecker S; Moschovitis A; Wahl A; Bühler I; Wyss C; Kozerke S; Landmesser U; Lüscher TF; Corti R
    Circulation; 2013 May; 127(19):1968-79. PubMed ID: 23596006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow cell transplantation improves cardiac, autonomic, and functional indexes in acute anterior myocardial infarction patients (Cardiac Study).
    Piepoli MF; Vallisa D; Arbasi M; Cavanna L; Cerri L; Mori M; Passerini F; Tommasi L; Rossi A; Capucci A;
    Eur J Heart Fail; 2010 Feb; 12(2):172-80. PubMed ID: 20042424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous CD133+ bone marrow cells and bypass grafting for regeneration of ischaemic myocardium: the Cardio133 trial.
    Nasseri BA; Ebell W; Dandel M; Kukucka M; Gebker R; Doltra A; Knosalla C; Choi YH; Hetzer R; Stamm C
    Eur Heart J; 2014 May; 35(19):1263-74. PubMed ID: 24497345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial.
    Meyer GP; Wollert KC; Lotz J; Steffens J; Lippolt P; Fichtner S; Hecker H; Schaefer A; Arseniev L; Hertenstein B; Ganser A; Drexler H
    Circulation; 2006 Mar; 113(10):1287-94. PubMed ID: 16520413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.